Calreticulin Mutation Status Predicts Improved Disease Outcome in Prefibrotic Primary Myelofibrosis but Not in WHO-Defined Essential Thrombocythemia

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image